miR-31: a master regulator of metastasis? (Q39917967)

15 September 2017

miR-31: a master regulator of metastasis? (English)

1 reference

15 September 2017

1

Thomas D Schmittgen

1 reference

PubMed ID

20021205

15 September 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

15 September 2017

1 reference

15 September 2017

6

1 reference

15 September 2017

1

1 reference

15 September 2017

17-20

1 reference

Metastamir: the field of metastasis-regulatory microRNA is spreading

15 September 2017

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.150

MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.150

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.150

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.150

MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.150

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.150

MicroRNAs as regulators of epithelial-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.150

A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.150

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.150

Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.150

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.150

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.150

Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.150

Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.150

Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.150

Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.150

MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.150

MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.150

Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.09.150

21 January 2018

Identifiers

DOI

10.2217/FON.09.150

1 reference

15 September 2017

1 reference

PubMed ID

20021205